Biogen (BIIB) Revenue — Quarter Ended Mar 31, 2025
Revenue for the current quarter declined compared to the immediately preceding quarter, but rose compared to the same quarter one year earlier. The trailing twelve-month revenue remained at a level consistent with recent performance.
Key takeaway
Quarter ended Mar 31, 2025 · FY2025 Q1
Revenue for the current quarter declined compared to the immediately preceding quarter, but rose compared to the same quarter one year earlier. The trailing twelve-month revenue remained at a level consistent with recent performance.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$2.4B
Revenue reported for this quarter.
Quarter-over-quarter
-1.0%
Change from the immediately preceding quarter.
Year-over-year
+6.1%
Change from the comparable year-ago quarter.
Trailing four quarters
$9.8B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2024 | $2.5B | +0.4% |
| Sep 30, 2024 | $2.5B | -2.5% |
| Dec 31, 2024 | $2.5B | +2.9% |
| Mar 31, 2025 | $2.4B | +6.1% |
Revenue performance
The reported revenue moved lower from the prior quarter, reflecting a slight sequential decrease. On a year-over-year basis, however, revenue showed growth.
Quarterly comparison
When measured against the preceding three-month period, revenue edged down. In contrast, compared to the same period a year ago, revenue increased.
What to watch
The company's revenue trend may warrant monitoring given the mix of sequential decline and annual growth.